Panru Biotechnology
Tianjin · Founded 2022
About Panru Biotechnology
Panru Biotechnology develops immunotherapy technology for prostate cancer.
Company Facts
- Founded: 2022
- Legal name: Panru Biotechnology (Tianjin) Co., Ltd.,
- Operating status: Operating
- IPO status: Private
- Funding stage: Seed
- Last round: Angel (Jan 2026)
Canonical: https://fsome.com/organization/panru-biotechnology-8338849 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.